Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Endocyte ECYT

Healthcare Biotechnology
"Endocyte Inc is a biopharmaceutical company. It is engaged in developing targeted therapies for the treatment of cancer and inflammatory diseases."

Recent & Breaking News (NDAQ:ECYT)

Mid-Morning Market Update: Markets Edge Hogher; Lululemon Beats Q1 Estimates

Benzinga.com  June 2, 2017

Endocyte Announces Clinical Updates for EC1456 and EC1169

GlobeNewswire June 2, 2017

Endocyte to Announce Updated Data on EC1456 and EC1169 at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire May 26, 2017

Mid-Afternoon Market Update: Inpixon Drops Following Q1 Results; Technical Communications Shares Spike Higher

Benzinga.com  May 12, 2017

Endocyte Reports First Quarter Financial Results and Provides Clinical and Pipeline Update

GlobeNewswire May 10, 2017

Investor Network: Endocyte, Inc. to Host Earnings Call

Accesswire May 10, 2017

Endocyte Announces First Quarter 2017 Earnings Conference Call

GlobeNewswire May 3, 2017

Endocyte Presents Data at AACR Identifying Multiple Methods for Managing Severe Side Effects Resulting from CAR T-Cell Treatment

GlobeNewswire April 5, 2017

Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2017

GlobeNewswire March 27, 2017

Endocyte Reports Fourth Quarter and Year End 2016 Financial Results and Provides Clinical and Pipeline Update

GlobeNewswire March 10, 2017

Endocyte and Seattle Children’s Research Institute to Collaborate on Endocyte’s Small Molecule Drug Conjugate Bi-Specific Adaptor Molecules for CAR T-cell Therapies

GlobeNewswire March 10, 2017

Endocyte Announces Fourth Quarter and Full Year 2016 Earnings Conference Call

GlobeNewswire March 2, 2017

Endocyte to Present at the Cowen and Company 37th Annual Health Care Conference

GlobeNewswire March 1, 2017

Endocyte Appoints Michael T. Andriole as Chief Financial Officer

GlobeNewswire February 21, 2017

Mission Therapeutics Appoints Colin Goddard as Chairman

PR Newswire December 5, 2016

Endocyte to Present at the IASLC 17th World Conference on Lung Cancer

GlobeNewswire December 1, 2016

Endocyte Reports Third Quarter 2016 Financial Results

GlobeNewswire November 9, 2016

Endocyte Announces Third Quarter 2016 Earnings Conference Call

GlobeNewswire November 2, 2016

Endocyte to Present at the 25th Annual Credit Suisse Healthcare Conference

GlobeNewswire November 1, 2016

Endocyte Presents Data on Two Lead Clinical Programs at European Society for Medical Oncology (ESMO) 2016 Congress

GlobeNewswire October 10, 2016